| Date Filed | Type | Description |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Chavant Capital Acquisition Corp.|
Txns:
| Disposed/sold 4,174 shares
@ $0 |
|
| 07/20/2021 |
3
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 3 on Chavant Capital Acquisition Corp. |
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2019 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Granted 7,500 options to buy
@ $3.16, valued at
$23.7k
|
|
| 04/09/2019 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 81,492 shares
@ $3.8875, valued at
$316.8k
|
|
| 08/20/2018 |
SC 13D/A
| AUBERTON-HERVE ANDRE-JACQUES reports a 6.2% stake in Bionik Laboratories Corp. |
| 07/26/2018 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 6,688,480 shares
@ $0.0513, valued at
$343.1k
|
|
| 06/15/2018 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 1,040,152 shares
@ $0.0625, valued at
$65k
Converted 1,039,115 shares
@ $0.0625, valued at
$64.9k
|
|
| 06/15/2018 |
3/A
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 3/A on Bionik Laboratories Corp. |
| 05/29/2018 |
SC 13D
| AUBERTON-HERVE ANDRE-JACQUES reports a 6.2% stake in Bionik Laboratories Corp. |
| 05/29/2018 |
3
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 3 on Bionik Laboratories Corp. |
| 04/03/2018 |
4
| AUBERTON-HERVE ANDRE-JACQUES (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 12,114,710 shares
@ $0.0625, valued at
$757.2k
Converted 564,726 shares
@ $0.0625, valued at
$35.3k
Granted 1,600,640 warrants
@ $0.0625, valued at
$100k
|
|